Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Blueberry Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11308
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, BB5000-NBE, to treat antimicrobial resistance, BB0109-NME developed for the treatment of inflammatory bowel disease and BB2702- NME used to treat atopic dermatitis. Blueberry Therapeutics provides peptides, protein and small molecules to treat infections. The company’s drug delivery system based on nanopolymer to self assembling. It operates through other pharmaceutical companies to develop new drug products. Blueberry Therapeutics is headquartered in Cheshire, the UK.

Blueberry Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Blueberry Therapeutics Raises USD12.7 Million in Series B Financing 10
Blueberry Therapeutics Raises USD4.4 Million in Venture Financing 11
Blueberry Therapeutics Raises USD1.75 Million in Financing Round 12
Partnerships 13
Blueberry Therapeutics Enters into Agreement with University of Sheffield and Sheffield Hallam University 13
Blueberry Therapeutics Enters into Agreement with University of Manchester for Antiflammatory Agents 14
Blueberry Therapeutics Enters into Agreement with University of Manchester and University of Liverpool 15
Licensing Agreements 16
Tecrea Enters into Licensing Agreement with Blueberry Therapeutics for Nanocin 16
Avacta Enters Into Licensing Agreement With Blueberry Therapeutics For Affimers 17
Blueberry Therapeutics Ltd – Key Competitors 18
Blueberry Therapeutics Ltd – Key Employees 19
Blueberry Therapeutics Ltd – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Product News 21
Jul 12, 2017: Blueberry to progress Nanomedicine platform to include novel Acne therapy 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blueberry Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Blueberry Therapeutics Raises USD12.7 Million in Series B Financing 10
Blueberry Therapeutics Raises USD4.4 Million in Venture Financing 11
Blueberry Therapeutics Raises USD1.75 Million in Financing Round 12
Blueberry Therapeutics Enters into Agreement with University of Sheffield and Sheffield Hallam University 13
Blueberry Therapeutics Enters into Agreement with University of Manchester for Antiflammatory Agents 14
Blueberry Therapeutics Enters into Agreement with University of Manchester and University of Liverpool 15
Tecrea Enters into Licensing Agreement with Blueberry Therapeutics for Nanocin 16
Avacta Enters Into Licensing Agreement With Blueberry Therapeutics For Affimers 17
Blueberry Therapeutics Ltd, Key Competitors 18
Blueberry Therapeutics Ltd, Key Employees 19

List of Figures
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blueberry Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BAE Systems Australia:企業の戦略・SWOT・財務情報
    BAE Systems Australia - Strategy, SWOT and Corporate Finance Report Summary BAE Systems Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Premier Marketing Public Company Limited:企業の戦略・SWOT・財務情報
    Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Rubis SCA (RUI):企業の財務・戦略的SWOT分析
    Rubis SCA (RUI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • British Business Bank Plc:企業の戦略的SWOT分析
    British Business Bank Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Guerbet SA (GBT)-医療機器分野:企業M&A・提携分析
    Summary Guerbet SA (Guerbet) is a specialty pharmaceutical company which manufactures and markets medical imaging contrast agents destined for diagnostic purposes. The company provides a wide range of contrast agents for X-ray examinations and Magnetic Resonance Imaging (MRI). Guerbet also provides …
  • Mitsubishi Logistics Corporation (9301):企業の財務・戦略的SWOT分析
    Mitsubishi Logistics Corporation (9301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sino Hotels (Holdings) Limited:企業の戦略・SWOT・財務分析
    Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Siliconware Precision Industries Co Ltd:企業の戦略的SWOT分析
    Siliconware Precision Industries Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Lumenis Ltd:企業の戦略的SWOT分析
    Lumenis Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Abraxas Petroleum Corp (AXAS):石油・ガス:M&Aディール及び事業提携情報
    Summary Abraxas Petroleum Corp (Abraxas) is an oil and gas company. The company offers exploration, production and development of oil and gas properties across the US. Its properties are located in Mid-Continent, Rocky Mountain, Gulf Coast and Permian Basin regions of the US. Abraxas’s Permian basin …
  • Highland Gold Mining Limited
    Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Catalent Inc:企業の戦略・SWOT・財務情報
    Catalent Inc - Strategy, SWOT and Corporate Finance Report Summary Catalent Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Bankrate, Inc.:企業のM&A・事業提携・投資動向
    Bankrate, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bankrate, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Northland Power Inc (NPI)-エネルギー分野:企業M&A・提携分析
    Summary Northland Power Inc. (Northland Power) is an independent power producer. It develops, finances, builds, owns, and operates clean and green power projects in Canada and internationally. The company generates energy from natural gas, biomass, landfill gas, wind and solar sources. In thermal ge …
  • American Air Filter Co Inc:企業の戦略的SWOT分析
    American Air Filter Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • EnCana Corporation:戦略・SWOT・企業財務分析
    EnCana Corporation - Strategy, SWOT and Corporate Finance Report Summary EnCana Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tata Teleservices (Maharashtra) Ltd (TTML):企業の財務・戦略的SWOT分析
    Tata Teleservices (Maharashtra) Ltd (TTML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Daidalos Solutions BV:企業の製品パイプライン分析2018
    Summary Daidalos Solutions BV (Daidalos Solutions) is a medical device company. The company offers products such as sutureless biological heart valve prostheses, sutureless mechanical heart valve prostheses, sutureless heart valve repair rings, sutureless working channels and ports, sutureless closi …
  • Olmuksan International Paper Ambalaj Sanayi ve Ticaret A.S.:企業の戦略・SWOT・財務情報
    Olmuksan International Paper Ambalaj Sanayi ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Olmuksan International Paper Ambalaj Sanayi ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers th …
  • Keck Seng Investments (Hong Kong) Ltd:企業の戦略・SWOT・財務情報
    Keck Seng Investments (Hong Kong) Ltd - Strategy, SWOT and Corporate Finance Report Summary Keck Seng Investments (Hong Kong) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆